Recent CFDA plans to speed up new drug approvals:1. March 21 – changes to approval process so data obtained from multiregional studies can be used towards NDAs. (Also see "Now Is The Time! Rule Changes To Smooth China New Drug Approvals?" - Pink Sheet, 21 March, 2017.)

2. March 16 - CFDA commissioner Bi Jinquan says foreign drugs “welcome in China”. (Also see "Foreign Drugs Welcome As China Reforms Progress: CFDA Commissioner" - Pink Sheet, 15 March, 2017.)

3. March 8 - CFDA prioritizes eCTDs, bioequivalence testing, data linkage for 2017. (Also see "China FDA Lays Out eCTDs, Bioequivalence, Patent Linkage As Priorities" - Pink Sheet, 9 March, 2017.)

China FDA Proposes Sweeping Reforms To Incentivize Innovation

More from China

More from Asia